Story perspectives
Amgen Launches Repatha Program to Cut Drug Costs
10/6/2025
26 2
1 of 1
Story summary
- Amgen launched AmgenNow, a direct-to-consumer program, on Oct 6, 2025, offering Repatha at $239/month.
- The program aims to lower drug prices amid pressure from President Trump.
- Discounts apply to uninsured patients.
- GoodRx will offer Repatha at the same price through 70,000+ pharmacies.
- Amgen plans portal integration with TrumpRx for direct purchases, with studies showing Repatha reduces events in high-risk patients.
